Literature DB >> 22258698

What is the utility of distal forearm DXA in primary hyperparathyroidism?

Kelly Wood1, Subarna Dhital, Herbert Chen, Rebecca S Sippel.   

Abstract

BACKGROUND: Primary hyperparathyroidism (PHPT) leads to increased bone turnover, low bone mineral density, and increased fracture risk. These effects are, however, preferentially seen in the distal forearm, which is rich in cortical bone. This study aimed to determine how frequently the distal forearm T score was the worst T score and if this T score alone led to higher rate of diagnosis of osteopenia or osteoporosis.
MATERIALS AND METHODS: We retrospectively reviewed a prospective database of 300 patients undergoing parathyroidectomy at our institution between November 2000 and January 2009. The bone mineral density of the lumbar spine, total proximal femurs, and distal third of the nondominant radius was measured by dual x-ray absorptiometry. Data on bone density are reported as T scores.
RESULTS: The mean T scores were -1.30 ± 0.2 in the distal forearm, -1.0 ± 0.1 in the total proximal femurs, and -0.9 ± 0.1 in the spine. The distal forearm T score was the worst bone mineral density T score in 39% of patients. This T score alone led to an upstaging in diagnosis to osteopenia or osteoporosis in 9.4% of patients.
CONCLUSION: In patients with PHPT, the worst T score is commonly found in the distal forearm. This T score can identify additional patients with a diagnosis of osteopenia or osteoporosis. Distal forearm bone mineral density should, therefore, be assessed in all patients who have a diagnosis of PHPT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258698      PMCID: PMC3316917          DOI: 10.1634/theoncologist.2011-0285

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  16 in total

Review 1.  Bone densitometry in asymptomatic primary hyperparathyroidism.

Authors:  Paul D Miller; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

Review 2.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

3.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 4.  Primary hyperparathyroidism: lessons from bone histomorphometry.

Authors:  Erik Fink Eriksen
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

5.  Risk of subsequent fracture after low-trauma fracture in men and women.

Authors:  Jacqueline R Center; Dana Bliuc; Tuan V Nguyen; John A Eisman
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

6.  Primary hyperparathyroidism and the risk of fracture: a population-based study.

Authors:  S Khosla; L J Melton; R A Wermers; C S Crowson; W m O'Fallon; B l Riggs
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

7.  Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

Authors:  P Vestergaard; C L Mollerup; V G Frøkjaer; P Christiansen; M Blichert-Toft; L Mosekilde
Journal:  BMJ       Date:  2000-09-09

8.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

9.  Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.

Authors:  Clive S Grant; Geoffrey Thompson; David Farley; Jon van Heerden
Journal:  Arch Surg       Date:  2005-05

10.  Skeletal disease in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; L de la Cruz; D W Dempster; F Feldman; D Seldin; T P Jacobs; E S Siris; M Cafferty; M V Parisien
Journal:  J Bone Miner Res       Date:  1989-06       Impact factor: 6.741

View more
  4 in total

1.  Mild primary hyperparathyroidism as defined in the Italian Society of Endocrinology's Consensus Statement: prevalence and clinical features.

Authors:  E Castellano; F Tassone; R Attanasio; L Gianotti; M Pellegrino; G Borretta
Journal:  J Endocrinol Invest       Date:  2015-11-30       Impact factor: 4.256

2.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

3.  Discordant interpretation of serial bone mineral density measurements by dual-energy X-ray absorptiometry using vendor's and institutional least significant changes: Serious impact on decision-making.

Authors:  Nosheen Fatima; Maseeh Uz Zaman; Sadaf Saleem; Noureen Hameed; Jamila Bano
Journal:  World J Nucl Med       Date:  2018 Oct-Dec

4.  Hyperparathyroidism Jaw Tumor Syndrome Presenting as Recurrent Femur Fractures in a Young Woman; a Rare Presentation of a Rare Disease.

Authors:  Piyumi S A Wijewickrama; Noel P Somasundaram
Journal:  Case Rep Endocrinol       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.